The evaluation of the effect of jyuzentaihoto on fatigue and NK cell function

The evaluation of the effect of jyuzentaihoto on fatigue and NK cell function - The evaluation of the effect of jyuzentaihoto on fatigue and NK cell function

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021332

Enrollment

Registered

2016-03-04

Start date

2015-01-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fatigue

Interventions

jyuzentaihoto

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: No subjective symptom, drinking three times or less a week, and normal liver and renal function that has been confirmed in a medical examination within one year.

Exclusion criteria

Exclusion criteria: Any of the following: currently receiving a drug therapy, currently having chronic diseases such as heart, lung, kidney, gastrointestinal, and inflammatory diseases, suffering from invasive cancer within five years, suffering from non-invasive cancer within a year, and a history of smoking within one year.

Design outcomes

Primary

Measure	Time frame
NK cell function	—

Secondary

Measure	Time frame
Numerical Rating Scale and questionnaires of general fatigue	—

Countries

Japan

Contacts

Public ContactKeiko Ogawa

Kanazawa University Hospital Department of Kampo Medicine

okeiko@med.kanazawa-u.ac.jp09060322222

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026